Metolazone As Early Add On Therapy For Acute Decompensated Heart Failure (MELT-HF)--A Single Center Pilot Study. (MELT-HF)
Sponsor: Aultman Health Foundation
Terminated
Limited resources available to met accrual goal.
Other terminated trials from Aultman Health Foundation
Other Acute Decompensated Heart Failure trials with similar outcome
A PHASE3 clinical study on Acute Decompensated Heart Failure, this trial is terminated or withdrawn. The trial is conducted by Aultman Health Foundation and has accumulated 9 data snapshots since 2015. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE3
-
Mar 2019 — Jan 2021 [monthly]
Terminated PHASE3
Status: Completed → Terminated
▶ Show 4 earlier versions
-
Oct 2018 — Mar 2019 [monthly]
Completed PHASE3
Status: Recruiting → Completed · Phase: PHASE2 → PHASE3
-
Jun 2018 — Oct 2018 [monthly]
Recruiting PHASE2
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE2
First recorded
Oct 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Aultman Health Foundation
For direct contact, visit the study record on ClinicalTrials.gov .